BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hertig A, Watnick S, Strevens H, Boulanger H, Berkane N, Rondeau E. How should women with pre-eclampsia be followed up? New insights from mechanistic studies. Nat Rev Nephrol 2008;4:503-9. [DOI: 10.1038/ncpneph0880] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Hertig A, Fort J, Lefevre G, Chabbert-buffet N, Uzan M, Rondeau E, Rozenberg P. Soluble endoglin in preeclamptic patients with or without HELLP syndrome. American Journal of Obstetrics and Gynecology 2010;202:594.e1-4. [DOI: 10.1016/j.ajog.2010.03.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
2 Mckay DB, Josephson M. Pregnancy in renal transplant recipients. Dial Transplant 2010;39:472-5. [DOI: 10.1002/dat.20511] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Sandvik MK, Iversen BM, Irgens LM, Skjaerven R, Leivestad T, Søfteland E, Vikse BE. Are adverse pregnancy outcomes risk factors for development of end-stage renal disease in women with diabetes? Nephrol Dial Transplant 2010;25:3600-7. [PMID: 20494895 DOI: 10.1093/ndt/gfq275] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
4 Kaze FF, Njukeng FA, Kengne AP, Ashuntantang G, Mbu R, Halle MP, Asonganyi T. Post-partum trend in blood pressure levels, renal function and proteinuria in women with severe preeclampsia and eclampsia in Sub-Saharan Africa: a 6-months cohort study. BMC Pregnancy Childbirth 2014;14:134. [PMID: 24712704 DOI: 10.1186/1471-2393-14-134] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
5 Boulanger H, Lefèvre G, Ahriz Saksi S, Achiche J, Bailleul S, Ekoukou D, Drouin D, Sault C, Stawiarski N, Dupuis E. [Potential value of placental angiogenic factors as biomarkers in preeclampsia for clinical physicians]. Nephrol Ther 2019;15:413-29. [PMID: 30935786 DOI: 10.1016/j.nephro.2018.10.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
6 Falkegård M, Schirmer H, Løchen ML, Øian P, Acharya G. The validity of self-reported information about hypertensive disorders of pregnancy in a population-based survey: the Tromsø Study. Acta Obstet Gynecol Scand 2015;94:28-34. [PMID: 25250917 DOI: 10.1111/aogs.12514] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
7 Hamano T. Women with a history of preeclampsia should be monitored for the onset and progression of chronic kidney disease. Nat Rev Nephrol 2009;5:8-9. [DOI: 10.1038/ncpneph0991] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
8 Noe KH, Pack AM. WOMEN'S ISSUES AND EPILEPSY: . CONTINUUM: Lifelong Learning in Neurology 2010;16:159-78. [DOI: 10.1212/01.con.0000368237.49610.93] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
9 Lui NA, Jeyaram G, Henry A. Postpartum Interventions to Reduce Long-Term Cardiovascular Disease Risk in Women After Hypertensive Disorders of Pregnancy: A Systematic Review. Front Cardiovasc Med 2019;6:160. [PMID: 31803757 DOI: 10.3389/fcvm.2019.00160] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
10 Hertig A, Liere P, Chabbert-Buffet N, Fort J, Pianos A, Eychenne B, Cambourg A, Schumacher M, Berkane N, Lefevre G, Uzan S, Rondeau E, Rozenberg P, Rafestin-Oblin ME. Steroid profiling in preeclamptic women: evidence for aromatase deficiency. Am J Obstet Gynecol 2010;203:477.e1-9. [PMID: 20691412 DOI: 10.1016/j.ajog.2010.06.011] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 4.7] [Reference Citation Analysis]
11 Borja-Del-Rosario P, Basu SK, Haberman S, Bhutada A, Rastogi S. Neonatal serum magnesium concentrations are determined by total maternal dose of magnesium sulfate administered for neuroprotection. J Perinat Med 2014;42:207-11. [PMID: 24006314 DOI: 10.1515/jpm-2013-0151] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
12 Usui J, Glezerman IG, Salvatore SP, Chandran CB, Flombaum CD, Seshan SV. Clinicopathological spectrum of kidney diseases in cancer patients treated with vascular endothelial growth factor inhibitors: a report of 5 cases and review of literature. Hum Pathol. 2014;45:1918-1927. [PMID: 25087655 DOI: 10.1016/j.humpath.2014.05.015] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 4.6] [Reference Citation Analysis]